Legal & General Group’s Natus Medical Inc NTUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-97,585
| Closed | -$3.2M | – | 3541 |
|
|
2022
Q2 | $3.2M | Buy |
97,585
+763
| +0.8% | +$24.1K | ﹤0.01% | 1636 |
|
|
2022
Q1 | $2.54M | Sell |
96,822
-918
| -0.9% | -$22.4K | ﹤0.01% | 1880 |
|
|
2021
Q4 | $2.32M | Buy |
97,740
+2,826
| +3% | +$69.7K | ﹤0.01% | 1968 |
|
|
2021
Q3 | $2.38M | Buy |
94,914
+6,931
| +8% | +$177K | ﹤0.01% | 1937 |
|
|
2021
Q2 | $2.29M | Sell |
87,983
-22,606
| -20% | -$615K | ﹤0.01% | 1909 |
|
|
2021
Q1 | $2.83M | Buy |
110,589
+6,793
| +7% | +$174K | ﹤0.01% | 1830 |
|
|
2020
Q4 | $2.08M | Hold |
103,796
| – | – | ﹤0.01% | 1873 |
|
|
2020
Q3 | $1.78M | Buy |
103,796
+49
| +0% | +$926 | ﹤0.01% | 1810 |
|
|
2020
Q2 | $2.26M | Buy |
103,747
+5,670
| +6% | +$130K | ﹤0.01% | 1679 |
|
|
2020
Q1 | $2.27M | Buy |
98,077
+1,367
| +1% | +$39.7K | ﹤0.01% | 1529 |
|
|
2019
Q4 | $3.19M | Buy |
96,710
+6,198
| +7% | +$199K | ﹤0.01% | 1580 |
|
|
2019
Q3 | $2.88M | Buy |
90,512
+1,433
| +2% | +$41.8K | ﹤0.01% | 1554 |
|
|
2019
Q2 | $2.29M | Buy |
89,079
+693
| +0.8% | +$17.7K | ﹤0.01% | 1632 |
|
|
2019
Q1 | $2.24M | Buy |
88,386
+7,329
| +9% | +$219K | ﹤0.01% | 1657 |
|
|
2018
Q4 | $2.75M | Buy |
81,057
+4,808
| +6% | +$156K | ﹤0.01% | 1424 |
|
|
2018
Q3 | $2.7M | Buy |
76,249
+5,528
| +8% | +$195K | ﹤0.01% | 1555 |
|
|
2018
Q2 | $2.46M | Buy |
70,721
+1,508
| +2% | +$52.9K | ﹤0.01% | 1562 |
|
|
2018
Q1 | $2.31M | Buy |
69,213
+4,496
| +7% | +$142K | ﹤0.01% | 1543 |
|
|
2017
Q4 | $2.47M | Buy |
64,717
+1,035
| +2% | +$41.3K | ﹤0.01% | 1506 |
|
|
2017
Q3 | $2.39M | Sell |
63,682
-73
| -0.1% | -$2.58K | ﹤0.01% | 1480 |
|
|
2017
Q2 | $2.38M | Buy |
63,755
+5,563
| +10% | +$201K | ﹤0.01% | 1429 |
|
|
2017
Q1 | $2.28M | Buy |
58,192
+421
| +0.7% | +$15.8K | ﹤0.01% | 1395 |
|
|
2016
Q4 | $2.01M | Buy |
57,771
+26,664
| +86% | +$1.05M | ﹤0.01% | 1388 |
|
|
2016
Q3 | $1.22M | Buy |
31,107
+22,100
| +245% | +$881K | ﹤0.01% | 1316 |
|
|
2016
Q2 | $337K | Hold |
9,007
| – | – | ﹤0.01% | 1543 |
|
|
2016
Q1 | $349K | Buy |
9,007
+1,918
| +27% | +$71.4K | ﹤0.01% | 1500 |
|
|
2015
Q4 | $344K | Hold |
7,089
| – | – | ﹤0.01% | 1487 |
|
|
2015
Q3 | $274K | Hold |
7,089
| – | – | ﹤0.01% | 1542 |
|
|
2015
Q2 | $301K | Buy |
7,089
+691
| +11% | +$27.5K | ﹤0.01% | 1537 |
|
|
2015
Q1 | $252K | Buy |
6,398
+1,618
| +34% | +$59.7K | ﹤0.01% | 1579 |
|
|
2014
Q4 | $172K | Hold |
4,780
| – | – | ﹤0.01% | 1653 |
|
|
2014
Q3 | $139K | Buy |
+4,780
| New | +$132K | ﹤0.01% | 1696 |
|
Other funds holding NTUS
Legal & General Group's NTUS Position: Q3 2022 in Review
Legal & General Group sold out of Natus Medical Inc (NTUS) in Q3 2022, closing a stake of 97,585 shares — an estimated $3.2M sold.
Legal & General Group first reported a position in NTUS in Q3 2014 and held it in 32 quarters. The position peaked at $3.2M in Q2 2022. 1 fund tracked by Wall St. Rank holds NTUS as of Q3 2022.
- Legal & General Group reported no remaining Natus Medical Inc position as of Q3 2022 after selling out during the quarter.
- Legal & General Group sold 97,585 Natus Medical Inc shares in Q3 2022, an estimated $3.2M.
- Legal & General Group first reported a position in Natus Medical Inc in Q3 2014 and held it in 32 quarters.
- Legal & General Group's Natus Medical Inc position peaked at $3.2M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Natus Medical Inc as of Q3 2022.
Based on Legal & General Group's 13F filing for Q3 2022, filed 14 Nov 2022.